Picture of Statera Biopharma logo

STAB — Statera Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Cytocom Q2 Loss Per Share Of $0.04

Aug 16 (Reuters) - Cytocom Inc  CBLI.O :
    * Q2 LOSS PER SHARE $0.04
    * EXPECTS ITS CASH POSITION TO INCREASE TO $30 MILLION BY
END OF
AUGUST 2021
    * BELIEVES CASH POSITION, OTHER CAPITAL SOURCES ARE
SUFFICIENT TO
FUND CONTINUED ADVANCEMENT OF CLINICAL-STAGE PIPELINE

Source text for Eikon: [https://bit.ly/2UraqiA]
Further company coverage:  CBLI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Statera Biopharma

See all news